Recent AKYA News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/11/2025 12:40:22 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/11/2025 12:39:37 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/11/2025 12:39:13 AM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 07/08/2025 05:06:41 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 07/08/2025 04:24:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/08/2025 01:23:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/07/2025 08:04:32 PM
- Form DEFM14A - Definitive proxy statement relating to merger or acquisition • Edgar (US Regulatory) • 06/16/2025 03:03:33 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 06/04/2025 08:01:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/02/2025 09:52:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/02/2025 08:05:19 PM
- Kent Lake Responds to Quanterix's Post-Effective Amendment and Akoya's Superior $1.40-per-Share Alternative Proposal • PR Newswire (US) • 05/23/2025 06:21:00 PM
- New Data and Deal Flow Signal a Turning Point for Precision-Driven Cancer Biotechs • PR Newswire (US) • 05/23/2025 01:10:00 PM
- New Data and Deal Flow Signal a Turning Point for Precision-Driven Cancer Biotechs • PR Newswire (Canada) • 05/23/2025 01:10:00 PM
- New Data and Deal Flow Signal a Turning Point for Precision-Driven Cancer Biotechs • PR Newswire (US) • 05/23/2025 01:10:00 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 05/12/2025 08:11:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/12/2025 08:10:15 PM
- Akoya Biosciences Reports First Quarter 2025 Financial Results • GlobeNewswire Inc. • 05/12/2025 08:05:00 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 04/29/2025 09:17:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/29/2025 09:15:35 PM
- Quanterix and Akoya Biosciences Announce Amended Merger Agreement • Business Wire • 04/29/2025 11:00:00 AM
Glidelogic Corp. Announces Release of First AI-Generated Novel "The Thirteenth Proposal" • GDLG • Jul 11, 2025 12:20 PM
Fifty1 AI Labs' REVIVE Clinical Trial Redefines Long COVID Treatment, Pioneering AI-Driven Therapies and Propelling Fifty 1 Labs, Inc. Toward $50M Valuation and Global Biotech Leadership • FITY • Jul 10, 2025 8:30 AM
Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB™, its New Sublingual Pre-Workout Supplement • ASBP • Jul 9, 2025 9:15 AM
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers • IBRX • Jul 9, 2025 9:00 AM
Fifty 1 Labs, Inc. Announces Bold Expansion Plan Powered by Nobel Prize Laureate Management Team, Cutting-Edge AI Healthcare Innovation and $350K Leadership Investment • FITY • Jul 8, 2025 8:30 AM
Avant Technologies and Partner, Ainnova, Launch Transformative Preventative Care Model for Chronic Patients Across Latin America • AVAI • Jul 8, 2025 8:00 AM